![Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6604999/MediaObjects/41416_2009_Article_BF6604999_Fig7_HTML.jpg)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond | British Journal of Cancer
![Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience - ScienceDirect Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265018300661-fx1.jpg)
Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience - ScienceDirect
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3 | PLOS ONE
![JCI Insight - DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma JCI Insight - DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma](https://df6sxcketz7bb.cloudfront.net/manuscripts/153000/153836/medium/jci.insight.153836.ga.jpg)
JCI Insight - DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
![The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1 | NEJM The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1 | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1990/nejm_1990.322.issue-3/nejm199001183220305/20130822/images/img_medium/nejm199001183220305_t1.jpeg)
The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1 | NEJM
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia | Haematologica
![Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine - Graham Dunn, Richard Emsley, Hanhua Liu, Sabine Landau, 2013 Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine - Graham Dunn, Richard Emsley, Hanhua Liu, Sabine Landau, 2013](https://journals.sagepub.com/cms/10.1177/1740774513499651/asset/images/large/10.1177_1740774513499651-fig3.jpeg)
Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine - Graham Dunn, Richard Emsley, Hanhua Liu, Sabine Landau, 2013
![Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond. | Semantic Scholar Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/64ae1784b57ce49dd0a57af1f508df5c1062ec6c/7-Table2-1.png)
Clinical and molecular prognostic markers of survival after surgery for gastric cancer: tumor-node-metastasis staging system and beyond. | Semantic Scholar
![Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/7/3947/F1.large.jpg)
Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast Cancer | Anticancer Research
![IJMS | Free Full-Text | A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma IJMS | Free Full-Text | A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma](https://www.mdpi.com/ijms/ijms-24-06688/article_deploy/html/images/ijms-24-06688-g001.png)
IJMS | Free Full-Text | A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
![High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/attachment/99e40aa8-00aa-4a73-a4cc-fbdbdc266dd1/gr1_lrg.jpg)